HEADER TRANSCRIPTION 16-MAR-18 6G07
TITLE RORGT (264-518;C455S) IN COMPLEX WITH INVERSE AGONIST "CPD-9" AND
TITLE 2 RIP140 PEPTIDE AT 1.66A
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA;
COMPND 3 CHAIN: A, B, C, D;
COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, LIGAND BINDING DOMAIN;
COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1
COMPND 6 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED
COMPND 7 ORPHAN RECEPTOR-GAMMA;
COMPND 8 ENGINEERED: YES;
COMPND 9 MUTATION: YES;
COMPND 10 MOL_ID: 2;
COMPND 11 MOLECULE: NUCLEAR RECEPTOR-INTERACTING PROTEIN 1;
COMPND 12 CHAIN: P, Q, R, S;
COMPND 13 FRAGMENT: UNP RESIDUES 493-512;
COMPND 14 SYNONYM: NUCLEAR FACTOR RIP140,RECEPTOR-INTERACTING PROTEIN 140
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28-DERIVED VECTOR;
SOURCE 11 MOL_ID: 2;
SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 13 ORGANISM_COMMON: HUMAN;
SOURCE 14 ORGANISM_TAXID: 9606
KEYWDS FBS, NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, INVERSE
KEYWDS 2 AGONIST, TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR J.KALLEN
REVDAT 4 17-JAN-24 6G07 1 REMARK
REVDAT 3 03-OCT-18 6G07 1 REMARK
REVDAT 2 22-AUG-18 6G07 1 JRNL
REVDAT 1 18-JUL-18 6G07 0
JRNL AUTH D.A.CARCACHE,A.VULPETTI,J.KALLEN,H.MATTES,D.ORAIN,
JRNL AUTH 2 R.STRINGER,E.VANGREVELINGHE,R.M.WOLF,K.KAUPMANN,J.OTTL,
JRNL AUTH 3 J.DAWSON,N.G.COOKE,K.HOEGENAUER,A.BILLICH,J.WAGNER,
JRNL AUTH 4 C.GUNTERMANN,S.HINTERMANN
JRNL TITL OPTIMIZING A WEAKLY BINDING FRAGMENT INTO A POTENT ROR GAMMA
JRNL TITL 2 T INVERSE AGONIST WITH EFFICACY IN AN IN VIVO INFLAMMATION
JRNL TITL 3 MODEL.
JRNL REF J. MED. CHEM. V. 61 6724 2018
JRNL REFN ISSN 1520-4804
JRNL PMID 29990434
JRNL DOI 10.1021/ACS.JMEDCHEM.8B00529
REMARK 2
REMARK 2 RESOLUTION. 1.66 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.38
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 3 NUMBER OF REFLECTIONS : 116225
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.215
REMARK 3 R VALUE (WORKING SET) : 0.214
REMARK 3 FREE R VALUE : 0.233
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 6118
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 8339
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 124
REMARK 3 SOLVENT ATOMS : 800
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 28.10
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.60
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.11000
REMARK 3 B22 (A**2) : 0.06000
REMARK 3 B33 (A**2) : -0.16000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.01000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.125
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.112
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.075
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.193
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY
REMARK 4
REMARK 4 6G07 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAR-18.
REMARK 100 THE DEPOSITION ID IS D_1200009212.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 26-APR-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00004
REMARK 200 MONOCHROMATOR : SI 111 CHANNEL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 122345
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660
REMARK 200 RESOLUTION RANGE LOW (A) : 19.380
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 200 DATA REDUNDANCY : 3.400
REMARK 200 R MERGE (I) : 0.04000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8
REMARK 200 DATA REDUNDANCY IN SHELL : 3.30
REMARK 200 R MERGE FOR SHELL (I) : 0.39100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 5NTI
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 40.21
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG3350, 0.2M AMMONIUM ACETATE,
REMARK 280 0.1M BIS-TRIS, PH 5.5, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.02900
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3, 4
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 960 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12400 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, P
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 960 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12990 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, Q
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12570 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, R
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 4
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1000 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12770 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, S
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 262
REMARK 465 PRO A 263
REMARK 465 GLU A 509
REMARK 465 THR A 510
REMARK 465 GLU A 511
REMARK 465 SER A 512
REMARK 465 PRO A 513
REMARK 465 VAL A 514
REMARK 465 GLY A 515
REMARK 465 LEU A 516
REMARK 465 SER A 517
REMARK 465 LYS A 518
REMARK 465 ASN P 493
REMARK 465 SER P 494
REMARK 465 HIS P 495
REMARK 465 GLN P 496
REMARK 465 LYS P 497
REMARK 465 VAL P 498
REMARK 465 LYS P 508
REMARK 465 ASN P 509
REMARK 465 GLU P 510
REMARK 465 GLU P 511
REMARK 465 ASN P 512
REMARK 465 GLY B 262
REMARK 465 PRO B 263
REMARK 465 GLU B 509
REMARK 465 THR B 510
REMARK 465 GLU B 511
REMARK 465 SER B 512
REMARK 465 PRO B 513
REMARK 465 VAL B 514
REMARK 465 GLY B 515
REMARK 465 LEU B 516
REMARK 465 SER B 517
REMARK 465 LYS B 518
REMARK 465 ASN Q 493
REMARK 465 SER Q 494
REMARK 465 HIS Q 495
REMARK 465 GLN Q 496
REMARK 465 LYS Q 497
REMARK 465 ASN Q 509
REMARK 465 GLU Q 510
REMARK 465 GLU Q 511
REMARK 465 ASN Q 512
REMARK 465 GLY C 262
REMARK 465 PRO C 263
REMARK 465 THR C 510
REMARK 465 GLU C 511
REMARK 465 SER C 512
REMARK 465 PRO C 513
REMARK 465 VAL C 514
REMARK 465 GLY C 515
REMARK 465 LEU C 516
REMARK 465 SER C 517
REMARK 465 LYS C 518
REMARK 465 ASN R 493
REMARK 465 SER R 494
REMARK 465 HIS R 495
REMARK 465 GLN R 496
REMARK 465 LYS R 497
REMARK 465 LYS R 508
REMARK 465 ASN R 509
REMARK 465 GLU R 510
REMARK 465 GLU R 511
REMARK 465 ASN R 512
REMARK 465 GLY D 262
REMARK 465 PRO D 263
REMARK 465 GLU D 509
REMARK 465 THR D 510
REMARK 465 GLU D 511
REMARK 465 SER D 512
REMARK 465 PRO D 513
REMARK 465 VAL D 514
REMARK 465 GLY D 515
REMARK 465 LEU D 516
REMARK 465 SER D 517
REMARK 465 LYS D 518
REMARK 465 ASN S 493
REMARK 465 SER S 494
REMARK 465 HIS S 495
REMARK 465 GLN S 496
REMARK 465 LYS S 497
REMARK 465 LYS S 508
REMARK 465 ASN S 509
REMARK 465 GLU S 510
REMARK 465 GLU S 511
REMARK 465 ASN S 512
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 286 -78.14 78.70
REMARK 500 GLN B 286 -82.85 73.55
REMARK 500 GLN C 286 -80.16 75.73
REMARK 500 GLU C 435 68.12 -111.66
REMARK 500 GLN D 286 -75.42 76.66
REMARK 500 GLU D 435 67.08 -117.61
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EEZ A 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EEZ B 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EEZ C 601
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EEZ D 601
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6FZU RELATED DB: PDB
REMARK 900 RELATED ID: 6G05 RELATED DB: PDB
DBREF 6G07 A 263 518 UNP P51449 RORG_HUMAN 263 518
DBREF 6G07 P 493 512 UNP P48552 NRIP1_HUMAN 493 512
DBREF 6G07 B 263 518 UNP P51449 RORG_HUMAN 263 518
DBREF 6G07 Q 493 512 UNP P48552 NRIP1_HUMAN 493 512
DBREF 6G07 C 263 518 UNP P51449 RORG_HUMAN 263 518
DBREF 6G07 R 493 512 UNP P48552 NRIP1_HUMAN 493 512
DBREF 6G07 D 263 518 UNP P51449 RORG_HUMAN 263 518
DBREF 6G07 S 493 512 UNP P48552 NRIP1_HUMAN 493 512
SEQADV 6G07 GLY A 262 UNP P51449 EXPRESSION TAG
SEQADV 6G07 SER A 455 UNP P51449 CYS 455 ENGINEERED MUTATION
SEQADV 6G07 GLY B 262 UNP P51449 EXPRESSION TAG
SEQADV 6G07 SER B 455 UNP P51449 CYS 455 ENGINEERED MUTATION
SEQADV 6G07 GLY C 262 UNP P51449 EXPRESSION TAG
SEQADV 6G07 SER C 455 UNP P51449 CYS 455 ENGINEERED MUTATION
SEQADV 6G07 GLY D 262 UNP P51449 EXPRESSION TAG
SEQADV 6G07 SER D 455 UNP P51449 CYS 455 ENGINEERED MUTATION
SEQRES 1 A 257 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL
SEQRES 2 A 257 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU
SEQRES 3 A 257 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE
SEQRES 4 A 257 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET
SEQRES 5 A 257 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU
SEQRES 6 A 257 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER
SEQRES 7 A 257 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU
SEQRES 8 A 257 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET
SEQRES 9 A 257 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE
SEQRES 10 A 257 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU
SEQRES 11 A 257 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER
SEQRES 12 A 257 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE
SEQRES 13 A 257 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG
SEQRES 14 A 257 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN
SEQRES 15 A 257 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS
SEQRES 16 A 257 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS
SEQRES 17 A 257 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG
SEQRES 18 A 257 LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL VAL GLN
SEQRES 19 A 257 ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE SER THR
SEQRES 20 A 257 GLU THR GLU SER PRO VAL GLY LEU SER LYS
SEQRES 1 P 20 ASN SER HIS GLN LYS VAL THR LEU LEU GLN LEU LEU LEU
SEQRES 2 P 20 GLY HIS LYS ASN GLU GLU ASN
SEQRES 1 B 257 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL
SEQRES 2 B 257 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU
SEQRES 3 B 257 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE
SEQRES 4 B 257 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET
SEQRES 5 B 257 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU
SEQRES 6 B 257 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER
SEQRES 7 B 257 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU
SEQRES 8 B 257 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET
SEQRES 9 B 257 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE
SEQRES 10 B 257 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU
SEQRES 11 B 257 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER
SEQRES 12 B 257 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE
SEQRES 13 B 257 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG
SEQRES 14 B 257 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN
SEQRES 15 B 257 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS
SEQRES 16 B 257 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS
SEQRES 17 B 257 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG
SEQRES 18 B 257 LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL VAL GLN
SEQRES 19 B 257 ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE SER THR
SEQRES 20 B 257 GLU THR GLU SER PRO VAL GLY LEU SER LYS
SEQRES 1 Q 20 ASN SER HIS GLN LYS VAL THR LEU LEU GLN LEU LEU LEU
SEQRES 2 Q 20 GLY HIS LYS ASN GLU GLU ASN
SEQRES 1 C 257 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL
SEQRES 2 C 257 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU
SEQRES 3 C 257 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE
SEQRES 4 C 257 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET
SEQRES 5 C 257 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU
SEQRES 6 C 257 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER
SEQRES 7 C 257 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU
SEQRES 8 C 257 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET
SEQRES 9 C 257 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE
SEQRES 10 C 257 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU
SEQRES 11 C 257 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER
SEQRES 12 C 257 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE
SEQRES 13 C 257 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG
SEQRES 14 C 257 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN
SEQRES 15 C 257 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS
SEQRES 16 C 257 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS
SEQRES 17 C 257 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG
SEQRES 18 C 257 LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL VAL GLN
SEQRES 19 C 257 ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE SER THR
SEQRES 20 C 257 GLU THR GLU SER PRO VAL GLY LEU SER LYS
SEQRES 1 R 20 ASN SER HIS GLN LYS VAL THR LEU LEU GLN LEU LEU LEU
SEQRES 2 R 20 GLY HIS LYS ASN GLU GLU ASN
SEQRES 1 D 257 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL
SEQRES 2 D 257 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU
SEQRES 3 D 257 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE
SEQRES 4 D 257 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET
SEQRES 5 D 257 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU
SEQRES 6 D 257 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER
SEQRES 7 D 257 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU
SEQRES 8 D 257 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET
SEQRES 9 D 257 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE
SEQRES 10 D 257 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU
SEQRES 11 D 257 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER
SEQRES 12 D 257 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE
SEQRES 13 D 257 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG
SEQRES 14 D 257 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN
SEQRES 15 D 257 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS
SEQRES 16 D 257 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS
SEQRES 17 D 257 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG
SEQRES 18 D 257 LEU GLN ILE PHE GLN HIS LEU HIS PRO ILE VAL VAL GLN
SEQRES 19 D 257 ALA ALA PHE PRO PRO LEU TYR LYS GLU LEU PHE SER THR
SEQRES 20 D 257 GLU THR GLU SER PRO VAL GLY LEU SER LYS
SEQRES 1 S 20 ASN SER HIS GLN LYS VAL THR LEU LEU GLN LEU LEU LEU
SEQRES 2 S 20 GLY HIS LYS ASN GLU GLU ASN
HET EEZ A 601 31
HET EEZ B 601 31
HET EEZ C 601 31
HET EEZ D 601 31
HETNAM EEZ ~{N}-[5-CHLORANYL-6-[(1~{S})-1-PHENYLETHOXY]PYRIDIN-3-
HETNAM 2 EEZ YL]-2-(4-ETHYLSULFONYLPHENYL)ETHANAMIDE
FORMUL 9 EEZ 4(C23 H23 CL N2 O4 S)
FORMUL 13 HOH *800(H2 O)
HELIX 1 AA1 SER A 266 GLU A 283 1 18
HELIX 2 AA2 ARG A 288 GLN A 295 1 8
HELIX 3 AA3 ARG A 296 ASN A 298 5 3
HELIX 4 AA4 SER A 301 ARG A 310 1 10
HELIX 5 AA5 SER A 312 LEU A 338 1 27
HELIX 6 AA6 LEU A 338 LEU A 344 1 7
HELIX 7 AA7 CYS A 345 MET A 365 1 21
HELIX 8 AA8 GLY A 384 GLY A 392 5 9
HELIX 9 AA9 CYS A 393 ALA A 409 1 17
HELIX 10 AB1 SER A 413 ILE A 426 1 14
HELIX 11 AB2 GLU A 435 THR A 457 1 23
HELIX 12 AB3 ARG A 459 LEU A 466 5 8
HELIX 13 AB4 PRO A 468 HIS A 490 1 23
HELIX 14 AB5 HIS A 490 PHE A 498 1 9
HELIX 15 AB6 PRO A 499 SER A 507 1 9
HELIX 16 AB7 LEU P 500 GLY P 506 1 7
HELIX 17 AB8 SER B 266 GLU B 283 1 18
HELIX 18 AB9 ARG B 288 GLN B 295 1 8
HELIX 19 AC1 ARG B 296 ASN B 298 5 3
HELIX 20 AC2 SER B 301 ARG B 310 1 10
HELIX 21 AC3 SER B 312 LEU B 338 1 27
HELIX 22 AC4 CYS B 345 MET B 365 1 21
HELIX 23 AC5 GLY B 384 GLY B 392 5 9
HELIX 24 AC6 CYS B 393 ALA B 409 1 17
HELIX 25 AC7 SER B 413 ILE B 426 1 14
HELIX 26 AC8 GLU B 435 THR B 457 1 23
HELIX 27 AC9 ARG B 459 LEU B 466 5 8
HELIX 28 AD1 GLY B 470 HIS B 490 1 21
HELIX 29 AD2 ILE B 492 PHE B 498 1 7
HELIX 30 AD3 PRO B 499 SER B 507 1 9
HELIX 31 AD4 THR Q 499 GLY Q 506 1 8
HELIX 32 AD5 SER C 266 GLU C 283 1 18
HELIX 33 AD6 ARG C 288 GLN C 295 1 8
HELIX 34 AD7 ARG C 296 ASN C 298 5 3
HELIX 35 AD8 SER C 301 LYS C 311 1 11
HELIX 36 AD9 SER C 312 LEU C 338 1 27
HELIX 37 AE1 CYS C 345 MET C 365 1 21
HELIX 38 AE2 GLY C 384 GLY C 392 5 9
HELIX 39 AE3 CYS C 393 ALA C 409 1 17
HELIX 40 AE4 SER C 413 ILE C 426 1 14
HELIX 41 AE5 GLU C 435 THR C 457 1 23
HELIX 42 AE6 ARG C 459 LEU C 466 5 8
HELIX 43 AE7 GLY C 470 HIS C 490 1 21
HELIX 44 AE8 HIS C 490 PHE C 498 1 9
HELIX 45 AE9 PRO C 499 SER C 507 1 9
HELIX 46 AF1 THR R 499 GLY R 506 1 8
HELIX 47 AF2 SER D 266 GLU D 283 1 18
HELIX 48 AF3 ARG D 288 GLN D 295 1 8
HELIX 49 AF4 ARG D 296 ASN D 298 5 3
HELIX 50 AF5 SER D 301 ARG D 310 1 10
HELIX 51 AF6 SER D 312 LEU D 338 1 27
HELIX 52 AF7 GLY D 340 LEU D 344 5 5
HELIX 53 AF8 CYS D 345 MET D 365 1 21
HELIX 54 AF9 GLY D 384 GLY D 392 5 9
HELIX 55 AG1 CYS D 393 ALA D 409 1 17
HELIX 56 AG2 SER D 413 ILE D 426 1 14
HELIX 57 AG3 GLU D 435 THR D 457 1 23
HELIX 58 AG4 ARG D 459 LEU D 463 5 5
HELIX 59 AG5 GLY D 470 HIS D 490 1 21
HELIX 60 AG6 HIS D 490 PHE D 498 1 9
HELIX 61 AG7 PRO D 499 SER D 507 1 9
HELIX 62 AG8 THR S 499 LEU S 505 1 7
SHEET 1 AA1 3 TYR A 369 ASN A 370 0
SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370
SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378
SHEET 1 AA2 3 TYR B 369 ASN B 370 0
SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370
SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378
SHEET 1 AA3 3 TYR C 369 ASN C 370 0
SHEET 2 AA3 3 THR C 375 PHE C 378 -1 O THR C 375 N ASN C 370
SHEET 3 AA3 3 LYS C 381 GLY C 383 -1 O LYS C 381 N PHE C 378
SHEET 1 AA4 3 TYR D 369 ASN D 370 0
SHEET 2 AA4 3 THR D 375 PHE D 378 -1 O THR D 375 N ASN D 370
SHEET 3 AA4 3 LYS D 381 GLY D 383 -1 O LYS D 381 N PHE D 378
SITE 1 AC1 16 CYS A 285 GLN A 286 LEU A 287 CYS A 320
SITE 2 AC1 16 HIS A 323 ARG A 364 MET A 365 ARG A 367
SITE 3 AC1 16 ALA A 368 PHE A 377 PHE A 378 PHE A 388
SITE 4 AC1 16 ILE A 397 ILE A 400 SER A 404 HOH A 795
SITE 1 AC2 18 CYS B 285 GLN B 286 LEU B 287 LEU B 292
SITE 2 AC2 18 CYS B 320 HIS B 323 LEU B 324 LEU B 362
SITE 3 AC2 18 ARG B 364 MET B 365 ARG B 367 ALA B 368
SITE 4 AC2 18 PHE B 377 PHE B 378 PHE B 388 ILE B 400
SITE 5 AC2 18 SER B 404 HOH B 763
SITE 1 AC3 15 CYS C 285 GLN C 286 LEU C 287 HIS C 323
SITE 2 AC3 15 LEU C 324 ARG C 364 MET C 365 ARG C 367
SITE 3 AC3 15 ALA C 368 PHE C 377 PHE C 378 PHE C 388
SITE 4 AC3 15 ILE C 400 SER C 404 HOH C 720
SITE 1 AC4 16 CYS D 285 GLN D 286 LEU D 287 HIS D 323
SITE 2 AC4 16 LEU D 324 ARG D 364 MET D 365 ARG D 367
SITE 3 AC4 16 ALA D 368 PHE D 377 PHE D 378 PHE D 388
SITE 4 AC4 16 ILE D 397 ILE D 400 SER D 404 HOH D 767
CRYST1 85.935 68.058 96.522 90.00 110.83 90.00 P 1 21 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011637 0.000000 0.004426 0.00000
SCALE2 0.000000 0.014693 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011084 0.00000